Stock Groups

U.S. govt to buy 10 million courses of Pfizer’s COVID-19 pill for $5.29 billion -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO : This undated handout photo taken by Reuters November 16th, 2021 shows Paxlovid (a Pfizer pill for coronavirus disease COVID-19), being manufactured in Ascoli. Handout by Pfizer

(Reuters) -Pfizer Inc announced that the U.S. government has signed a $5.29 Billion deal to purchase 10,000,000 COVID-19 antiviral drugs for delivery in 2022.

If approved Pfizer (NYSE:) stated that it will supply the drug starting in 2018 and ending in 2022.

Secretary of the United States Department of Health and Human Services, Xavier Becerra said that “this promising treatment could accelerate our path to this pandemic and offer another life-saving tool in people who become sick with COVID-19.”

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information, including buy/sell signal data. You should be aware of the potential risks and financial costs involved in trading the financial market. It is one the most dangerous investment types.



[ad_2]